Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 2
2007 3
2008 3
2009 2
2011 3
2012 1
2013 7
2014 8
2015 8
2016 5
2017 7
2018 12
2019 8
2020 16
2021 16
2022 18
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Imaging of Pheochromocytoma and Paraganglioma.
Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, Pacak K. Carrasquillo JA, et al. Among authors: pryma da. J Nucl Med. 2021 Aug 1;62(8):1033-1042. doi: 10.2967/jnumed.120.259689. J Nucl Med. 2021. PMID: 34330739 Free PMC article.
High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.
Jha A, Taïeb D, Carrasquillo JA, Pryma DA, Patel M, Millo C, de Herder WW, Del Rivero J, Crona J, Shulkin BL, Virgolini I, Chen AP, Mittal BR, Basu S, Dillon JS, Hope TA, Mari Aparici C, Iagaru AH, Hicks RJ, Avram AM, Strosberg JR, Civelek AC, Lin FI, Pandit-Taskar N, Pacak K. Jha A, et al. Among authors: pryma da. Clin Cancer Res. 2021 Jun 1;27(11):2989-2995. doi: 10.1158/1078-0432.CCR-20-3703. Epub 2021 Mar 8. Clin Cancer Res. 2021. PMID: 33685867 Free PMC article. Review.
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. Fishbein L, et al. Among authors: pryma da. Pancreas. 2021 Apr 1;50(4):469-493. doi: 10.1097/MPA.0000000000001792. Pancreas. 2021. PMID: 33939658
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi PM, Herati RS, Mansfield KD, Patsch D, Amaravadi RK, Schuchter LM, Ishwaran H, Mick R, Pryma DA, Xu X, Feldman MD, Gangadhar TC, Hahn SM, Wherry EJ, Vonderheide RH, Minn AJ. Twyman-Saint Victor C, et al. Among authors: pryma da. Nature. 2015 Apr 16;520(7547):373-7. doi: 10.1038/nature14292. Epub 2015 Mar 9. Nature. 2015. PMID: 25754329 Free PMC article.
Parathyroid imaging.
Fakhran S, Branstetter BF 4th, Pryma DA. Fakhran S, et al. Among authors: pryma da. Neuroimaging Clin N Am. 2008 Aug;18(3):537-49, ix. doi: 10.1016/j.nic.2008.03.006. Neuroimaging Clin N Am. 2008. PMID: 18656034 Review.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Weiss AR, Chen YL, Scharschmidt TJ, Chi YY, Tian J, Black JO, Davis JL, Fanburg-Smith JC, Zambrano E, Anderson J, Arens R, Binitie O, Choy E, Davis JW, Hayes-Jordan A, Kao SC, Kayton ML, Kessel S, Lim R, Meyer WH, Million L, Okuno SH, Ostrenga A, Parisi MT, Pryma DA, Randall RL, Rosen MA, Schlapkohl M, Shulkin BL, Smith EA, Sorger JI, Terezakis S, Hawkins DS, Spunt SL, Wang D. Weiss AR, et al. Among authors: pryma da. Lancet Oncol. 2020 Aug;21(8):1110-1122. doi: 10.1016/S1470-2045(20)30325-9. Epub 2020 Jul 20. Lancet Oncol. 2020. PMID: 32702309 Free PMC article. Clinical Trial.
Radiopharmaceutical Chemistry and Drug Development-What's Changed?
Kunos CA, Mankoff DA, Schultz MK, Graves SA, Pryma DA. Kunos CA, et al. Among authors: pryma da. Semin Radiat Oncol. 2021 Jan;31(1):3-11. doi: 10.1016/j.semradonc.2020.07.006. Semin Radiat Oncol. 2021. PMID: 33246634 Free PMC article. Review.
Introduction to Radiopharmaceutical Therapy.
O'Brien SR, Pryma DA. O'Brien SR, et al. Among authors: pryma da. Pract Radiat Oncol. 2022 Jul-Aug;12(4):285-288. doi: 10.1016/j.prro.2022.04.006. Pract Radiat Oncol. 2022. PMID: 35717041
Development of Companion Diagnostics.
Mankoff DA, Edmonds CE, Farwell MD, Pryma DA. Mankoff DA, et al. Among authors: pryma da. Semin Nucl Med. 2016 Jan;46(1):47-56. doi: 10.1053/j.semnuclmed.2015.09.002. Semin Nucl Med. 2016. PMID: 26687857 Free PMC article. Review.
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology.
Weiss AR, Chen YL, Scharschmidt TJ, Xue W, Gao Z, Black JO, Choy E, Davis JL, Fanburg-Smith JC, Kao SC, Kayton ML, Kessel S, Lim R, Million L, Okuno SH, Ostrenga A, Parisi MT, Pryma DA, Randall RL, Rosen MA, Shulkin BL, Terezakis S, Venkatramani R, Zambrano E, Wang D, Hawkins DS, Spunt SL. Weiss AR, et al. Among authors: pryma da. J Clin Oncol. 2023 Nov 1;41(31):4842-4848. doi: 10.1200/JCO.23.00045. Epub 2023 Jul 31. J Clin Oncol. 2023. PMID: 37523624 Clinical Trial.
115 results